Author: | Cohen, M. A. |
Article Title: | Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: Some reasons why |
Abstract: | There are several reasons that explain the false-negative core-needle biopsy rate for atypical lobular hyperplasia or lobular carcinoma in situ (LCIS): Some are technical, as in the failure to adequately target the lesion; some are interpretive, as in the misdiagnosis of low-grade solid ductal carcinoma in situ as LCIS; and some are biological, as would occur if a population of LCIS lesions were truly premalignant. |
Keywords: | immunohistochemistry; histopathology; review; treatment planning; diagnostic accuracy; evidence based medicine; diagnostic procedure; breast; differential diagnosis; breast neoplasms; uvomorulin; cancer invasion; mammography; diagnostic value; biopsy, needle; breast carcinoma; carcinoma in situ; hyperplasia; needle biopsy; diagnostic error; tamoxifen; radiodiagnosis; breast surgery; technique; carcinoma, intraductal, noninfiltrating; breast biopsy; carcinoma, lobular; breast hyperplasia; precancer; tamoxifen citrate; humans; human; female; priority journal; breast, biopsy; breast, neoplasms, diagnosis; editorials; breast atypical lobular hyperplasia |
Journal Title: | Radiology |
Volume: | 231 |
Issue: | 3 |
ISSN: | 0033-8419 |
Publisher: | Radiological Society of North America, Inc. |
Date Published: | 2004-06-01 |
Start Page: | 617 |
End Page: | 621 |
Language: | English |
DOI: | 10.1148/radiol.2313040154 |
PROVIDER: | scopus |
PUBMED: | 15163803 |
DOI/URL: | |
Notes: | Radiology -- Cited By (since 1996):40 -- Export Date: 16 June 2014 -- CODEN: RADLA -- Source: Scopus |